Abstract
Recently, 1997, Tanner and co-workers provided a new scale converting TW-RUS standard maturity scores to skeletal age for European North American youths (US90). The aim of the present study was to test if the accuracy of TW-RUS bone age assessments in the Italian population could be improved by evaluating the estimates obtained with this new scale in comparison with other standards (UK60: original British series, B70: Belgian series and S80: Spanish series). 1,831 hand-wrist radiographs (Italian healthy subjects aged from 8 to 16.8 years) were evaluated. The US90 reference values are resulted the most suitable TW-RUS standards. Therefore, it seems useful to update the reference values of TW-RUS SMS in Italian youths, using this new scale.
References
1.
Tanner JM, Whitehouse RH, Cameron N, Marshall W, Healy MJR, Goldstein H: Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method), ed 2. London, Academic Press, 1983.
2.
Wenzel A, Melsen B: Skeletal maturity in 6–16-year-old Danish children assessed by the Tanner-Whitehouse-2 method. Ann Hum Biol 1982;9:277–281.
3.
Wenzel A, Droschl H, Melsen B: Skeletal maturity in Austrian children assessed by the GP and the TW-2 methods. Ann Hum Biol 1984;2:173–177.
4.
Beunen G, Lefevre J, Ostyn M, Renson R, Simons J, Van Gerven D: Skeletal maturity in Belgian youths assessed by the Tanner-Whitehouse method (TW2). Ann Hum Biol 1990;17:335–376.
5.
Nicoletti I, Cheli D, Cocco E, Pucetti L, Salvi A, Socci A: Contributo allo studio della maturazione ossea nella popolazione italiana. Acta Med Auxol 1976;8:5–48.
6.
Peris M, Manzi P, Martire M, Pastorin L, Rota A, Benso L: La maturazione scheletrica a Torino in confronto agli standard britannici (maschi tra i 6 e gli 11 anni). Min Pediatr 1983;35:959–960.
7.
Vignolo M, Milani S, Di Battista E, Naselli A, Mostert M, Aicardi G: Modified Greulich-Pyle, Tanner-Whitehouse and Roche-Wainer-Thissen and adolescents. Eur J Pediatr 1990;149:314–318.
8.
Vignolo M, Milani S, Cerbello G, Coroli P, Di Battista E, Aicardi G: FELS, Greulich-Pyle, and Tanner-Whitehouse bone age assessments in a group of Italian children and adolescents. Am J Hum Biol 1992;4:493–500.
9.
Hernàndez M, Sànchez E, Sobradillo B, Rincòn JM: Skeletal Maturation and Height Prediction: Atlas and Scoring Methods. Madrid, Diaz de Santos, 1991.
10.
Eto M, Ashizawa K: Longitudinal Observations on Physical Growth and TW2 Skeletal Maturation of Girls in Tokyo. Radiographic Atlas of Hand and Wrist. Tokyo, Therapeia, 1992.
11.
Tanner J M, Oshman D, Babbage F, Healy M: Tanner-Whitehouse bone age reference values for North American Children. J Paediatr 1997;131:34–40.
12.
Tanner JM, Whitehouse RH: Clinical longitudinal standard of height, weight, height velocity, weight velocity and the stages of puberty. Arch Dis Child 1976;51:170–179.
13.
SAS Institute Inc.: SAS introductory guide for personal computers. Version 6, Cary, NC, SAS Institute Inc, 1985.
14.
Baughan B, Demirjian A, Levesque GY: Skeletal maturity standards for French-Canadian children of school-age with a discussion of the reliability and validity of such measures. Hum Biol 1979;51:353–370.
15.
Kimura K: Skeletal maturation in Japanese according to the Oxford and Tanner-Whitehouse methods. Acta Anat Nippon 1972;47:358–372.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.